SEC Form 4 · accession 0000019446-17-000072
CANTEL MEDICAL CORP · CMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
George L Fotiades
Director
Period of report
Dec 18, 2017
Accepted (ET)
Dec 19, 2017 · 7:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.10 per shareF1 | Dec 18, 2017 | S | 5,700 | $101.085 | D | 94,366 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The per share prices ranged from $101.04 to $101.15. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price.